Where does Beth Israel Deaconess Medical Center, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Beth Israel Deaconess Medical Center, Inc. ranks #1,584 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Beth Israel Deaconess Medical Center, Inc. hold?

Beth Israel Deaconess Medical Center, Inc. holds 261 US utility patents granted between 2015 and 2025, spanning 50 technology areas.

What is Beth Israel Deaconess Medical Center, Inc.'s Innovation Score?

Beth Israel Deaconess Medical Center, Inc. has an Innovation Score of 59.5 out of 100 (top 4% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Beth Israel Deaconess Medical Center, Inc. focus on?

Beth Israel Deaconess Medical Center, Inc.'s top technology area is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes) with 157 patents, ranking #112 of 7,163 assignees active in that subclass. Grants appear in 50 CPC subclasses total.

Is Beth Israel Deaconess Medical Center, Inc.'s patent grant rate increasing or decreasing?

Beth Israel Deaconess Medical Center, Inc.'s recent grant velocity is -26% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Beth Israel Deaconess Medical Center, Inc.'s patents?

Beth Israel Deaconess Medical Center, Inc.'s patents average 18.9 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Beth Israel Deaconess Medical Center, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Beth Israel Deaconess Medical Center, Inc.

USPTO PatentsView assignee record - 261 granted patents across 50 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61K (Preparations FOR Medical, Dental OR Toiletry Purposes).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Beth ranks #1,584 of 49,997 tracked US assignees by granted-patent volume, with 261 patents across 50 technology areas.

#1,584
of 49,997 US assignees by volume: Top 4%
by Innovation Score (59.5/100): 18.9
avg claims per patent: -26%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R1584 · US Corporation #1,584 · 261 grants

GRANTS-MID · TOP-DECILE · PHOTO-FINISH · CPC-WIDE · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · VEL-DOWN · BOOK-FULL

GRANTS-MID 261 grants
TOP-DECILE #1,584/49,997
PHOTO-FINISH Ememory Technology
CPC-WIDE A61K · 50 areas
INNOV-PAR 59.5/100
CLAIMS-RICH 18.9 claims/avg
TYPE-USCORP US Corporation
VEL-DOWN -26% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Ememory Technology Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Beth’s 59.5 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 19.2 pts (32%) Velocity 4.0 pts (7%) Breadth 25.0 pts (42%) Claim depth 11.3 pts (19%)

Qualcomm Incorporated · highest

85
Beihang University · near

60
Beth Israel… · this assignee

60
Cummins Emission… · near

60
Huawei Device · near

60
Xiamen Tianma… · near

60
3D Lighting… · lowest

7

What this shows Beth's Innovation Score is 59.5/100 (top 4% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Beth?

Each dot is one of Beth’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Beth’s own 18.9 claims/patent is ABOVE the 14.5 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Beth vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

How Beth's grant cadence moved

Between 2020–2024, Beth Israel Deaconess Medical Center, Inc. received 105 grants versus 141 in 2015–2019 (-26% equal-window velocity, below median growth). Across complete PatentsView years, output peaked in 2019 at 45 grants and bottomed in 2016 at 14. Lead class A61K accounts for 60.2% of the portfolio across 50 subclasses. Volume neighbours: Microjet Technology Co., Ltd. (#1,580) and Brocade Communications Systems LLC (#1,588).

Beth's three-year grant acceleration

From 2019–2021 to 2022–2024, Beth Israel Deaconess Medical Center, Inc. moved from 94 to 56 grants (0.60x the prior three-year total, a multiple, not a CAGR). Among 3,296 tracked assignees with ≥100 grants and ≥20 prior-period grants, that multiple ranks #2,459. See the growth leaderboard.

Microjet Technolo…

262
National Universi…

262
The Lubrizol

262
Unisantis Singapo…

262
Ememory Technology

261
Kyushu University…

261
Sharp Laboratorie…

261
Beth Israel Deaco… ◀

261
Brocade Communica…

260

What this shows Beth holds 261 patents at rank #1,584, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Beth

By rank, the assignees closest to #1,584 in granted patent volume.

Leaders in A61K (Preparations FOR Medical)

Other assignees with the most granted patents in Beth's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Beth, neither rank-band nor same-CPC leaders (those blocks stay above). In A61K (Preparations FOR Medical), Beth ranks #112 of 7,163 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (60 here).

Beihang University 60 Cummins Emission Solutions Inc. 60 Huawei Device Co., Ltd. 60 Xiamen Tianma Display Technology Co., Ltd. 60

Similar claim depth

Nearest assignees by average claims per patent (18.9 here).

Genesys Telecommunications Laboratories, Inc. 18.9 avg Cerner Innovation, Inc. 18.9 avg Lytx, Inc. 18.9 avg Abbyy Production LLC 18.9 avg

Beth's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

60 Top 4% higher than 96% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Beth Israel Deaconess Medical Center, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	19	7.3%
2016	14	5.4%
2017	26	10.0%
2018	37	14.2%
2019	45	17.2%
2020	22	8.4%
2021	27	10.3%
2022	22	8.4%
2023	17	6.5%
2024	17	6.5%
2025partial year	15	5.7%

Which technologies does Beth Israel Deaconess Medical Center, Inc. patent most?

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 157

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 117

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 81

C07K - Peptides 78

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 55

A61B - DIAGNOSIS; SURGERY; Identification 48

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 35

C07D - Heterocyclic Compounds 25

Y02A - Technologies FOR Adaptation TO Climate Change 22

G01R - Measuring Electric VARIABLES; Measuring Magnetic Variables 19

G16H - Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data 12

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy 11

C07C - Acyclic OR Carbocyclic Compounds 7

G06T - Image Data Processing OR Generation, IN General 7

C09B - Organic Dyes OR Closely-related Compounds FOR Producing Dyes ; , e.g. PIGMENTS; MORDANTS; Lakes 6

Top 15 of 50 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Beth Israel Deaconess Medical Center, Inc.'s patent record in context - here's where to go next.

Beth Israel Deaconess Medical Center, Inc.'s lead technology class is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes), 60.2% of its portfolio - see every assignee active in that class. Explore A61K
Ranked #1,584 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Beth Israel Deaconess Medical Center, Inc. against Microjet Technology Co., Ltd., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 59.5/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.